Payment overview · 2025
General Payments
$206.98
10 reported records · 5 companies
Healthcare provider profile · identity verified
Felicia Ann Bertram, ARNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · KNOXVILLE, TN · NPI 1326155573
Verified facts
What the public records show
CMS Open Payments records show Felicia Ann Bertram, ARNP received $206.98 in general payments during 2025 across 10 reported records.
Globus Medical, Inc. accounted for 34.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ztlido.
SCILEX PHARMACEUTICALS INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ZTLido as an associated drug or biological on 6923 records involving 3060 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Ztlido by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Globus Medical, Inc. | Unresolved — no canonical attribution shown | $70.70 | 34.2% | 3 | 2025 |
| SCILEX PHARMACEUTICALS INC. | Unresolved — no canonical attribution shown | $62.80 | 30.3% | 3 | 2025 |
| Collegium Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $31.30 | 15.1% | 2 | 2025 |
| TerSera Therapeutics LLC | Unresolved — no canonical attribution shown | $22.73 | 11.0% | 1 | 2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | Unresolved — no canonical attribution shown | $19.45 | 9.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $206.98 | 10 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Senza Normalized: senza |
Device | Globus Medical, Inc. | $70.70 | 3 | 2025 |
Source payment records
|
|||||
| ZTLido Normalized: ztlido |
Drug | SCILEX PHARMACEUTICALS INC. | $62.80 | 3 | 2025 |
Source payment records
|
|||||
| XTAMPZA Normalized: xtampza |
Drug | Collegium Pharmaceutical, Inc. | $31.30 | 2 | 2025 |
Source payment records
|
|||||
| Prialt Normalized: prialt |
Drug | TerSera Therapeutics LLC | $22.73 | 1 | 2025 |
Source payment records
|
|||||
| JOURNAVX Normalized: journavx |
Drug | VERTEX PHARMACEUTICALS INCORPORATED | $19.45 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ZTLido ztlido |
2025 | Ztlido | 2024 | 27 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| SCILEX PHARMACEUTICALS INC. Exact reporting entity; no affiliate inference |
2025 | ZTLido open payments reported associated product |
CMS Open Payments — General Payments 6923 supporting records · 3060 recipient NPIs · example record 1242585247 |
Ztlido · 2024 Exact normalized brand match · 1 Part D row |
27 | 14 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Oxycodone Hcl | Oxycodone Hcl | 1178 | 361 |
| Morphine Sulfate Er | Morphine Sulfate | 873 | 270 |
| Gabapentin | Gabapentin | 727 | 232 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 607 | 174 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 468 | 142 |
| Xtampza Er | Oxycodone Myristate | 369 | 123 |
| Tizanidine Hcl | Tizanidine Hcl | 272 | 106 |
| Atorvastatin Calcium | Atorvastatin Calcium | 247 | 105 |
| Pregabalin | Pregabalin | 246 | 82 |
| Fentanyl | Fentanyl | 211 | 78 |
| Levothyroxine Sodium | Levothyroxine Sodium | 202 | 82 |
| Losartan Potassium | Losartan Potassium | 167 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 165 | 60 |
| Baclofen | Baclofen | 163 | 65 |
| Metformin Hcl | Metformin Hcl | 152 | 59 |
| Amlodipine Besylate | Amlodipine Besylate | 150 | 70 |
| Omeprazole | Omeprazole | 146 | 47 |
| Lisinopril | Lisinopril | 134 | 65 |
| Trazodone Hcl | Trazodone Hcl | 120 | 43 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 114 | 53 |
| Diclofenac Sodium | Diclofenac Sodium | 105 | 46 |
| Pantoprazole Sodium | Pantoprazole Sodium | 102 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 100 | 48 |
| Montelukast Sodium | Montelukast Sodium | 100 | 32 |
| Ibuprofen | Ibuprofen | 96 | 32 |
| Sertraline Hcl | Sertraline Hcl | 93 | 29 |
| Eliquis | Apixaban | 91 | 28 |
| Tramadol Hcl | Tramadol Hcl | 87 | 25 |
| Simvastatin | Simvastatin | 84 | 32 |
| Hydromorphone Hcl | Hydromorphone Hcl | 83 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 80 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 79 | 36 |
| Meloxicam | Meloxicam | 74 | 37 |
| Methocarbamol | Methocarbamol | 74 | 29 |
| Carvedilol | Carvedilol | 73 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 73 | 29 |
| Furosemide | Furosemide | 72 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 68 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 65 | 21 |
| Famotidine | Famotidine | 64 | 19 |
| Oxymorphone Hcl Er | Oxymorphone Hcl | 64 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 61 | 26 |
| Amoxicillin | Amoxicillin | 60 | 55 |
| Oxycontin | Oxycodone Hcl | 58 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 56 | 14 |
| Naloxone Hcl | Naloxone Hcl | 55 | 54 |
| Fluticasone Propionate | Fluticasone Propionate | 53 | 25 |
| Morphine Sulfate | Morphine Sulfate | 52 | 16 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 51 | 21 |
| Clonidine Hcl | Clonidine Hcl | 50 | 19 |
| Diazepam | Diazepam | 50 | 17 |
| Movantik | Naloxegol Oxalate | 50 | 28 |
| Ozempic | Semaglutide | 46 | 21 |
| Lidocaine | Lidocaine | 45 | 18 |
| Ezetimibe | Ezetimibe | 42 | 19 |
| Azithromycin | Azithromycin | 41 | 38 |
| Atenolol | Atenolol | 40 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 39 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 38 | 17 |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 35 | 14 |
| Metformin Hcl Er | Metformin Hcl | 34 | 12 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 34 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 33 | 14 |
| Glipizide | Glipizide | 32 | 12 |
| Synthroid | Levothyroxine Sodium | 32 | 13 |
| Buspirone Hcl | Buspirone Hcl | 30 | 12 |
| Hysingla Er | Hydrocodone Bitartrate | 29 | 13 |
| Spironolactone | Spironolactone | 29 | suppressed |
| Allopurinol | Allopurinol | 28 | 13 |
| Jardiance | Empagliflozin | 27 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 27 | 13 |
| Ztlido | Lidocaine | 27 | 14 |
| Enalapril Maleate | Enalapril Maleate | 26 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 26 | suppressed |
| Finasteride | Finasteride | 24 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 24 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 23 | suppressed |
| Mounjaro | Tirzepatide | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 11 |
| Prednisone | Prednisone | 23 | 11 |
| Linzess | Linaclotide | 22 | 13 |
| Fluconazole | Fluconazole | 21 | 14 |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Belsomra | Suvorexant | 20 | suppressed |
| Celecoxib | Celecoxib | 20 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 20 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 20 | 20 |
| Valsartan | Valsartan | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Potassium Chloride | Potassium Chloride | 19 | 12 |
| Ramipril | Ramipril | 19 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 19 | suppressed |
| Xarelto | Rivaroxaban | 19 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 18 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 18 |
| Oxybutynin Chloride | Oxybutynin Chloride | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Topiramate | Topiramate | 17 | suppressed |
| Acyclovir | Acyclovir | 16 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 16 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 13 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Hydrocortisone | Hydrocortisone | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Desloratadine | Desloratadine | 13 | suppressed |
| Hydromorphone Er | Hydromorphone Hcl | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Sumatriptan | Sumatriptan | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Estradiol (Twice Weekly) | Estradiol | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | 11 |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $206.98 · 10 records | Globus Medical, Inc. | JOURNAVX, Prialt, Senza, XTAMPZA, ZTLido | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ztlido play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with SCILEX PHARMACEUTICALS INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error